In this interview, Anders Björklund speaks to us about how we might overcome the current limitations of using stem cell therapies for Parkinson’s disease.
Browsing: Movement disorders
Researchers from the University of Oregon (OR, USA) suggest that noninvasive EEG readings could present as easily detectable biomarkers to help diagnose and improve treatment for Parkinson’s and other motor disorders.
In this interview, we spoke with Viviane Labrie about her research into the vermiform appendix as a possible contributor to Parkinson’s disease.
Whilst at the AD/PD™ conference, we had the pleasure of speaking with Patrik Brundin about his talk on novel therapeutic targets for Parkinson’s disease.
People who were previously housebound with Parkinson’s disease are now able to walk more freely thanks to spinal stimulation treatment.
To mark World Parkinson’s Day, we’re taking the opportunity to look back on some of the research highlights in the field over the last year.
A recently published study has provided evidence that could potentially aid reports into dogs detecting an epileptic seizure odor.
A groundbreaking treatment that delivers a drug directly to the brain may offer hope to restore damaged brain cells in Parkinson’s disease.
Researchers have developed a ‘pacemaker for the brain’, which can monitor and stimulate electric currents, potentially leading to novel treatments in individuals with neurological diseases.
Voyager Therapeutics has announced the first patient dosed in RESTORE-1, a Phase II trial of VY-AADC gene therapy for the treatment of Parkinson’s disease.